Epigenetic heterogeneity is associated with genetic heterogeneity in CLL samples. Epigenetic heterogeneity is associated with genetic heterogeneity in.

Slides:

Advertisements

Similar presentations

Ivan P. Gorlov, Olga Y. Gorlova & Christopher I. Amos.

Advertisements

Making Sense of Novel Prognostics: NOTCH1, SF3B1 Jennifer R Brown, MD PhD Director, CLL Center Dana-Farber Cancer Institute October 24, 2014.

Supervisor: VS 高志平 Reporter: R4 張妙而.  Mutations in nucleophosmin 1 ( NPM1 ) gene, one of the most common gene mutations (25%-30%) in AML  NPM1 mut co-occurs.

The origin of metastatic disease: clues from genomics 7/13/2011.

Computational research for medical discovery at Boston College Biology Gabor T. Marth Boston College Department of Biology

Genetics-multistep tumorigenesis genomic integrity & cancer Sections from Weinberg’s ‘the biology of Cancer’ Cancer genetics and genomics Selected.

Computational Laboratory: aCGH Data Analysis Feb. 4, 2011 Per Chia-Chin Wu.

Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms by Pontus Lundberg, Axel Karow, Ronny Nienhold, Renate Looser,

Computational Biology and Genomics at Boston College Biology Gabor T. Marth Department of Biology, Boston College

FREQUENCY DISTRIBUTION

Chapter 16 Section 1 Genes and Variation

Somatic Mutation of the 5′ Noncoding Region of the BCL-6 Gene Is Associated with Intraclonal Diversity and Clonal Selection in Histological Transformation.

Kendy K. Wong, Ronald J. deLeeuw, Nirpjit S. Dosanjh, Lindsey R

Volume 147, Issue 1, (September 2011)

Genetic Variation Within Populations

Ewing sarcoma tumors acquire somatic aberrancies with treatment.

MiRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia by Christian Philipp Pallasch, Michaela.

Mohammed El-Kebir, Gryte Satas, Layla Oesper, Benjamin J. Raphael

Clonal evolution in Ewing sarcoma.

Mariëlle I. Gallegos Ruiz, MSc, Hester van Cruijsen, MD, Egbert F

CSCI2950-C Lecture 3 September 13, 2007.

High-Resolution Mapping of Genotype-Phenotype Relationships in Cri du Chat Syndrome Using Array Comparative Genomic Hybridization Xiaoxiao Zhang, Antoine.

Model of segmental duplication Acceptor regions of the genome acquire segments of genomic material that range from 1–200 kb from disparate regions.

A, relationship between weighted mean chromosome copy number and weighted Genome Instability Index (wGII). A, relationship between weighted mean chromosome.

Summary of the population genetics measures used in this study.

Mutational signatures associated with tobacco smoking in human cancer

Volume 7, Issue 1, Pages (April 2014)

Diverse abnormalities manifest in RNA

Epigenetic regulation of miR-193b in liposarcomagenesis.

Volume 150, Issue 6, Pages (September 2012)

What is allele frequency?

SNP Arrays in Heterogeneous Tissue: Highly Accurate Collection of Both Germline and Somatic Genetic Information from Unpaired Single Tumor Samples Guillaume.

Ashley M. Laughney, Sergi Elizalde, Giulio Genovese, Samuel F. Bakhoum

ROC curve for separating advanced stages (advanced BE and EA) versus early stages (BE or BE instability) using total genome-wide LOH [area under the curve.

Figure 2 Effect of chromosomal instability tolerance

MYD88 L265P mutation and CDKN2A loss are early mutational events in primary central nervous system diffuse large B-cell lymphomas by Naema Nayyar, Michael.

Chromosome 8 cDNA microarray gene expression profile of the amplified regions of 8p11–12 in SUM-44, -52, and -225 cells versus MCF10A HME control cells.

A, genomic copy number profiles of chromosome 8 with array CGH in SUM-44, -52, and A, genomic copy number profiles of chromosome 8 with array CGH.

Lesson Overview 17.1 Genes and Variation.

Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLL by Sabah Kadri, Jimmy Lee, Carrie Fitzpatrick,

Inferring Tumor Phylogenies from Multi-region Sequencing

High-Definition Reconstruction of Clonal Composition in Cancer

Temporal order of mutational processes during cancer evolution.

Kinetics of clone appearance, size, persistence, and lineage content.

High-level clonal amplification of FGFR2 predicts for sensitivity to FGFR inhibitor. High-level clonal amplification of FGFR2 predicts for sensitivity.

A: Spectrum of 136 somatic HNF1A mutations observed in 75 HCA samples (top) and in 364 MODY3 individuals (bottom) (data from Ellard and Colclough [25]).

BRCA1 promoter methylation detected in the peripheral blood and corresponding tumor. BRCA1 promoter methylation detected in the peripheral blood and corresponding.

Effect of nucleoside analogues on DNA repair response initiated by 4-HC. Effect of nucleoside analogues on DNA repair response initiated by 4-HC. A, CLL.

Temporal analysis of clonal evolution in typical FL and matched TFL samples. Temporal analysis of clonal evolution in typical FL and matched TFL samples.

Integrated mRNA and microRNA expression and DNA methylation clusters.

Overview of TIMER modules on the website.

Positions of the EGFR exon 20 insertions identified over a 3-year period and comparison with the spectrum of EGFR exon 19 and HER2 insertion mutations.

Tumor and serum levels of murine IL-12.

Gene copy number analysis by multiplexed quantitative differential PCR for BRCA1 and BRCA2 for 23 DNA specimens obtained from patients of Hispanic ancestry.

Validation of GHSR, SST, and ZIC1 in hrHPV-positive cervical scrapes and their relation to duration of lesion existence and DNA copy number aberrations.

Association between BRCA1 transcript level and cisplatin sensitivity, BRCA1 promoter methylation, and NtAI. Association between BRCA1 transcript level.

MPM cases with GNH. A, WES-based LOH profiling with the FACETS algorithm revealed three MPM samples with genome-wide LOH. B, Allelic copy-number plots.

Number of identical D-loop DNA clones detected in 10 DNA clones derived from liver tumor tissues. Number of identical D-loop DNA clones detected in 10.

Representative photograph of somatic mutations detected by PCR-SSCP.

Distribution of FGFR aberrancies in urothelial cancers.

Location of the ER mutations and frequencies per cohort.

A, heatmap of copy number alterations determined by array CGH for a panel of 79 frozen NSCLC samples. A, heatmap of copy number alterations determined.

PIK3CA somatic mutation and amplification frequency in prostate cancer

Detection of BRCA reversion mutations in pretreatment cfDNA and tumor biopsy. Detection of BRCA reversion mutations in pretreatment cfDNA and tumor biopsy.

High genomic fidelity of SCLC PDX models derived from both CTCs and biopsies. High genomic fidelity of SCLC PDX models derived from both CTCs and biopsies.

Driver pathways and key genes in OSCC

CASP8 mutations are associated with fewer CNAs and RAS family mutations. CASP8 mutations are associated with fewer CNAs and RAS family mutations. A, number.

Integrated analysis of gene expression and copy number alterations.

HER2 amplification in EGFRT790M–negative tumors with acquired resistance. HER2 amplification in EGFRT790M–negative tumors with acquired resistance. A,HER2.

Molecular characterization of esophagogastric tumors.

Presentation transcript:

Epigenetic heterogeneity is associated with genetic heterogeneity in CLL samples. Epigenetic heterogeneity is associated with genetic heterogeneity in CLL samples. A, quantitative assessment of the mutation/CNA clone sizes for various aberrations in two CLL samples representative of different levels of genetic heterogeneity. Clone sizes for various detected somatic aberrations (gray) are displayed for CLL48 and CLL109. For CLL48, all variations fall within a range consistent with a clonal sample population possessing monoallelic aberrations at 13q14, 17p13, and MYD88 and a single-copy gain of chromosome 12. For CLL109, individual somatic variations occur at a frequency indicative of intraclonal diversification, with the mutation clone size of the R625C mutation in SF3B1 representing approximately an even ratio of genetic clones. The most possible heterogeneous ratio of all mutations/CNAs is designated as the genetic clone ratio for a given sample. B, methylation heterogeneity levels of all CLL samples versus the genetic clone ratio. Biclonal samples are also displayed. Christopher C. Oakes et al. Cancer Discovery 2014;4:348-361 ©2014 by American Association for Cancer Research